Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.35 USD 13.56%
Updated: May 29, 2024

Mereo Biopharma Group PLC
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Net Change in Cash Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Net Change in Cash
-£38m
CAGR 3-Years
-63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Change in Cash
-$265.6m
CAGR 3-Years
-205%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Change in Cash
-$142.4m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Change in Cash
$163.7m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Change in Cash
£40.2m
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Change in Cash
-£300k
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
N/A

See Also

What is Mereo Biopharma Group PLC's Net Change in Cash?
Net Change in Cash
-38m GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Net Change in Cash amounts to -38m GBP.

What is Mereo Biopharma Group PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-63%

The average annual Net Change in Cash growth rates for Mereo Biopharma Group PLC have been -63% over the past three years .